Information Provided By:
Fly News Breaks for December 2, 2016
ACHC
Dec 2, 2016 | 07:37 EDT
Jefferies analyst Brian Tanquilut resumed coverage of Acadia Healthcare after the firm had been restricted on the stock, reinstating a Buy rating on the shares. Tanquilut believes the recent completion of its U.K. divestiture removes an overhang and expects organic growth to remain healthy amid strong demand for mental health services. He set a $55 price target on Acadia shares.